InsidersTradesSigma
Explore the full record of transactions filed by KREHER NERISSA, Directrice Médicale. Director active across 1 companies, notably Entrada Therapeutics, Inc.. Cumulatively, 3 disclosures have been recorded. The latest transaction was disclosed on 1 March 2022 — Attribution. Regulator: SEC (Form 4). The full history is openly available.
3 of 3 declarations
Nerissa Kreher is the Chief Medical Officer at Entrada Therapeutics, Inc. She oversees the clinical and medical operations of the company, ensuring that the treatments developed are safe and effective.